Review



primary antibodies against ki 67  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Cell Signaling Technology Inc primary antibodies against ki 67
    Primary Antibodies Against Ki 67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1247 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pm41864115-68-0-14?v=Cell+Signaling+Technology+Inc
    Average 97 stars, based on 1247 article reviews
    primary antibodies against ki 67 - by Bioz Stars, 2026-08
    97/100 stars

    Images



    Similar Products

    99
    Thermo Fisher rabbit anti ki 67 primary antibody
    Effect of roburic acid (RA) <t>on</t> <t>Ki-67</t> expression in colorectal cancer (CRC) cell lines. Ki-67 immunofluorescence staining in DLD-1, HCT-116, and HT-29 following 48 h of exposure to RA at concentrations corresponding to 0.5 × IC 50 and IC 50 . Quantitative data are presented as medians with interquartile ranges, minimums, and maximums. Statistical analysis was performed using the Kruskal–Wallis test, followed by Dunn’s post hoc test; an asterisk indicates significant differences relative to untreated controls (*) ( p < 0.05).
    Rabbit Anti Ki 67 Primary Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pmc12986222-210-9-13?v=Thermo+Fisher
    Average 99 stars, based on 1 article reviews
    rabbit anti ki 67 primary antibody - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc primary antibodies against ki 67
    Effect of roburic acid (RA) <t>on</t> <t>Ki-67</t> expression in colorectal cancer (CRC) cell lines. Ki-67 immunofluorescence staining in DLD-1, HCT-116, and HT-29 following 48 h of exposure to RA at concentrations corresponding to 0.5 × IC 50 and IC 50 . Quantitative data are presented as medians with interquartile ranges, minimums, and maximums. Statistical analysis was performed using the Kruskal–Wallis test, followed by Dunn’s post hoc test; an asterisk indicates significant differences relative to untreated controls (*) ( p < 0.05).
    Primary Antibodies Against Ki 67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pm41864115-68-0-14?v=Cell+Signaling+Technology+Inc
    Average 97 stars, based on 1 article reviews
    primary antibodies against ki 67 - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc primary antibody against ki67
    In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of <t>Ki67</t> IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.
    Primary Antibody Against Ki67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pmc12907050-471-0-8?v=Cell+Signaling+Technology+Inc
    Average 97 stars, based on 1 article reviews
    primary antibody against ki67 - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    96
    Proteintech primary antibodies include rabbit anti ki 67
    In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of <t>Ki67</t> IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.
    Primary Antibodies Include Rabbit Anti Ki 67, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pm41317401-428-1-8?v=Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibodies include rabbit anti ki 67 - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti ki67 primary antibody solution
    In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of <t>Ki67</t> IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.
    Anti Ki67 Primary Antibody Solution, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pmc12427454-127-33-41?v=Cell+Signaling+Technology+Inc
    Average 97 stars, based on 1 article reviews
    anti ki67 primary antibody solution - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc primary antibody anti ki 67
    In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of <t>Ki67</t> IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.
    Primary Antibody Anti Ki 67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/10__1016_slash_j__cej__2025__168569-36-0-6?v=Cell+Signaling+Technology+Inc
    Average 96 stars, based on 1 article reviews
    primary antibody anti ki 67 - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc primary anti ki67 antibody d2h10
    In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of <t>Ki67</t> IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.
    Primary Anti Ki67 Antibody D2h10, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/bio_rxiv__2025__08__27__672673-217-21-26?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    primary anti ki67 antibody d2h10 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc primary antibody rabbit anti human ki67
    Phenotypic characterization of the invasive feature and tumorigenic ability of E. coli strains. (A) Schematic diagram of microbial isolation from intestinal epithelial cells for in vitro and in vivo phenotypic assays. The invasive features, proliferation-inducing ability, and tumorigenic characteristics of the intraepithelial bacteria obtained from mouse colonocytes were evaluated in human cell lines and experimental murine models. (B) The intraepithelial E. coli strains (LI60C3, HM784C1, HM926C2, and HM936C4), adherent-invasive E. coli strains (LF82 and NC101), and nonpathogenic laboratory strains (MG1655, DH5α and JM109) were exposed to Caco-2 cells at MOI = 10 for 4 h. (a) Intracellular bacterial counts and (b) apical bacterial counts in the epithelial cultures are shown. (C) Cell cycle progression of Caco-2 cells after bacterial exposure for 24 h. The cell ratios in (a) S/G2/M to G1/G0 phase and (b) high to low <t>Ki67</t> staining intensity are shown. Data are expressed as mean ± SEM ( N = 5–8/group). Each dot represents the data of one sample. * P < 0.05 vs. w/o, and # P < 0.05 vs. LI60C3. (D) A murine model with chemically induced colon cancer was inoculated with PBS vehicle, LI60C3, or LF82 at 10 9 CFU per mouse via the orogastric route. Representative images of intestinal tumors in each mouse group are displayed. Bar: 2 mm (macroscopic images) and 200 μm (histological images, H&E staining). (E) Increased tumor load was observed in mice inoculated with LI60C3, but not LF82. The tumor (a) number, (b) area, and (c) grade were determined for each mouse. The percentages of tumors with low- and high-grade dysplasia and carcinoma in each group are presented. Data are expressed as mean ± SEM ( N = 8–10/group). Each dot represents the data of one mouse. * P < 0.05 vs. PBS, and # P < 0.05 vs. LI60C3. The statistical significance of all panels is calculated by ANOVA followed by Tukey’s multiple comparison test, except those of (B-a), (C-a) and (E-a) are determined by the Kruskal–Wallis test. Experiments were repeated at least twice.
    Primary Antibody Rabbit Anti Human Ki67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pmc12366417-221-43-51?v=Cell+Signaling+Technology+Inc
    Average 97 stars, based on 1 article reviews
    primary antibody rabbit anti human ki67 - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti ki 67 primary antibody
    Phenotypic characterization of the invasive feature and tumorigenic ability of E. coli strains. (A) Schematic diagram of microbial isolation from intestinal epithelial cells for in vitro and in vivo phenotypic assays. The invasive features, proliferation-inducing ability, and tumorigenic characteristics of the intraepithelial bacteria obtained from mouse colonocytes were evaluated in human cell lines and experimental murine models. (B) The intraepithelial E. coli strains (LI60C3, HM784C1, HM926C2, and HM936C4), adherent-invasive E. coli strains (LF82 and NC101), and nonpathogenic laboratory strains (MG1655, DH5α and JM109) were exposed to Caco-2 cells at MOI = 10 for 4 h. (a) Intracellular bacterial counts and (b) apical bacterial counts in the epithelial cultures are shown. (C) Cell cycle progression of Caco-2 cells after bacterial exposure for 24 h. The cell ratios in (a) S/G2/M to G1/G0 phase and (b) high to low <t>Ki67</t> staining intensity are shown. Data are expressed as mean ± SEM ( N = 5–8/group). Each dot represents the data of one sample. * P < 0.05 vs. w/o, and # P < 0.05 vs. LI60C3. (D) A murine model with chemically induced colon cancer was inoculated with PBS vehicle, LI60C3, or LF82 at 10 9 CFU per mouse via the orogastric route. Representative images of intestinal tumors in each mouse group are displayed. Bar: 2 mm (macroscopic images) and 200 μm (histological images, H&E staining). (E) Increased tumor load was observed in mice inoculated with LI60C3, but not LF82. The tumor (a) number, (b) area, and (c) grade were determined for each mouse. The percentages of tumors with low- and high-grade dysplasia and carcinoma in each group are presented. Data are expressed as mean ± SEM ( N = 8–10/group). Each dot represents the data of one mouse. * P < 0.05 vs. PBS, and # P < 0.05 vs. LI60C3. The statistical significance of all panels is calculated by ANOVA followed by Tukey’s multiple comparison test, except those of (B-a), (C-a) and (E-a) are determined by the Kruskal–Wallis test. Experiments were repeated at least twice.
    Anti Ki 67 Primary Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+ki+67+primary+antibody/pm40565174-236-15-19?v=Cell+Signaling+Technology+Inc
    Average 97 stars, based on 1 article reviews
    anti ki 67 primary antibody - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    Image Search Results


    Effect of roburic acid (RA) on Ki-67 expression in colorectal cancer (CRC) cell lines. Ki-67 immunofluorescence staining in DLD-1, HCT-116, and HT-29 following 48 h of exposure to RA at concentrations corresponding to 0.5 × IC 50 and IC 50 . Quantitative data are presented as medians with interquartile ranges, minimums, and maximums. Statistical analysis was performed using the Kruskal–Wallis test, followed by Dunn’s post hoc test; an asterisk indicates significant differences relative to untreated controls (*) ( p < 0.05).

    Journal: International Journal of Molecular Sciences

    Article Title: Roburic Acid as a Therapeutic Candidate: Antiproliferative Activity and Secondary Cell Death Response in Colorectal Cancer Cells

    doi: 10.3390/ijms27052478

    Figure Lengend Snippet: Effect of roburic acid (RA) on Ki-67 expression in colorectal cancer (CRC) cell lines. Ki-67 immunofluorescence staining in DLD-1, HCT-116, and HT-29 following 48 h of exposure to RA at concentrations corresponding to 0.5 × IC 50 and IC 50 . Quantitative data are presented as medians with interquartile ranges, minimums, and maximums. Statistical analysis was performed using the Kruskal–Wallis test, followed by Dunn’s post hoc test; an asterisk indicates significant differences relative to untreated controls (*) ( p < 0.05).

    Article Snippet: Samples were then incubated for 1 h with a rabbit anti-Ki-67 primary antibody (Thermo Fisher, MA5-14520; 1:250 dilution in PBS supplemented with 1% bovine serum albumin and 0.5% Tween-20), followed by a 1 h incubation with an Alexa Fluor 488-conjugated goat anti-rabbit IgG secondary antibody (Thermo Fisher, A-11008; 1:500 dilution).

    Techniques: Expressing, Immunofluorescence, Staining

    In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of Ki67 IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.

    Journal: iScience

    Article Title: HHEX-PRKAR2B axis-mediated PKA activation drives glucose metabolism-dependent progression of pancreatic ductal adenocarcinoma

    doi: 10.1016/j.isci.2026.114691

    Figure Lengend Snippet: In vivo demonstration of glucose-activated PKA promoting glycolysis-dependent progression A. Immunoblot analysis of PRKAR2B in KPC cells with or without PRKAR2B knockout. (B–D) Representative images of colony formation by KPC cells, with or without PRKAR2B knockout, cultured in normal or low-glucose medium (B). Colony size (C) and number of colonies (D) were graphed ( n = 3 independent repeats). Data were expressed as mean ± SD. Scale bars, 50 μm ∗, p < 0.05, ∗∗, p < 0.01, NS, no significance. (E) Representative H&E-stained pancreatic sections from mice with tamoxifen-inducible, pancreas-specific KRAS expression, harvested 3 weeks after tamoxifen or vehicle injection. Scale bars, 1 mm (F–H) PKA activity (F), pyruvic acid level (G), and lactate level (H) in pancreatic tissues from mice, harvested 3 weeks after tamoxifen or vehicle injection, assessing the effect of tamoxifen-inducible, pancreas-specific KRAS expression ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; ∗∗, p < 0.01. (I) Colorimetric analysis of PKA activity in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (J) Representative immunoblot of CREB, pCREB, and KLF5 in wild-type and diabetic mice ( n = 4 independent samples; see F for all replicates). (K) mRNA expression level of HK2 in wild-type and diabetic mice ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (L) Schematic diagram of the experimental design in mice. Pan02 cells with or without PRKAR2B knockout was injected into wild type or diabetic mouse through the tail vein ( n = 4 independent samples). (M) Changes in mouse body weight following tail vein injection of PRKAR2B -knockout or wild-type Pan02 cells ( n = 4 independent samples). Data were expressed as mean ± SD. ∗∗, p < 0.01. (N) Colorimetric analysis of PKA activity in tumor allografts from wild-type and diabetic mice with or without PRKAR2B knockout ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05, ∗∗, p < 0.01. (O) Representative image of Ki67 IHC staining in Pan02-control and Pan02- PRKAR2B -sg allografts from wild-type or diabetic mice ( n = 4 independent samples). Scale bars, 150 μm (P) Representative H&E-stained lung sections at the experimental endpoint. Scale bars, 3 mm (Q–R) Quantification of metastatic lesion number (Q) and total metastatic burden (R) at the experimental endpoint across the indicated treatment groups ( n = 4 independent samples). Data were expressed as mean ± SD. ∗, p < 0.05; NS, no significance.

    Article Snippet: Primary antibody against Ki67 (1:500 dilution, cat. 12202, Cell Signaling Technology, MA, USA) was prepared in SignalStain Antibody Diluent (cat. 8112, Cell Signaling Technology) and applied to the sections overnight at 4°C.

    Techniques: In Vivo, Western Blot, Knock-Out, Cell Culture, Staining, Expressing, Injection, Activity Assay, Immunohistochemistry, Control

    Phenotypic characterization of the invasive feature and tumorigenic ability of E. coli strains. (A) Schematic diagram of microbial isolation from intestinal epithelial cells for in vitro and in vivo phenotypic assays. The invasive features, proliferation-inducing ability, and tumorigenic characteristics of the intraepithelial bacteria obtained from mouse colonocytes were evaluated in human cell lines and experimental murine models. (B) The intraepithelial E. coli strains (LI60C3, HM784C1, HM926C2, and HM936C4), adherent-invasive E. coli strains (LF82 and NC101), and nonpathogenic laboratory strains (MG1655, DH5α and JM109) were exposed to Caco-2 cells at MOI = 10 for 4 h. (a) Intracellular bacterial counts and (b) apical bacterial counts in the epithelial cultures are shown. (C) Cell cycle progression of Caco-2 cells after bacterial exposure for 24 h. The cell ratios in (a) S/G2/M to G1/G0 phase and (b) high to low Ki67 staining intensity are shown. Data are expressed as mean ± SEM ( N = 5–8/group). Each dot represents the data of one sample. * P < 0.05 vs. w/o, and # P < 0.05 vs. LI60C3. (D) A murine model with chemically induced colon cancer was inoculated with PBS vehicle, LI60C3, or LF82 at 10 9 CFU per mouse via the orogastric route. Representative images of intestinal tumors in each mouse group are displayed. Bar: 2 mm (macroscopic images) and 200 μm (histological images, H&E staining). (E) Increased tumor load was observed in mice inoculated with LI60C3, but not LF82. The tumor (a) number, (b) area, and (c) grade were determined for each mouse. The percentages of tumors with low- and high-grade dysplasia and carcinoma in each group are presented. Data are expressed as mean ± SEM ( N = 8–10/group). Each dot represents the data of one mouse. * P < 0.05 vs. PBS, and # P < 0.05 vs. LI60C3. The statistical significance of all panels is calculated by ANOVA followed by Tukey’s multiple comparison test, except those of (B-a), (C-a) and (E-a) are determined by the Kruskal–Wallis test. Experiments were repeated at least twice.

    Journal: Gut Pathogens

    Article Title: Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3

    doi: 10.1186/s13099-025-00732-1

    Figure Lengend Snippet: Phenotypic characterization of the invasive feature and tumorigenic ability of E. coli strains. (A) Schematic diagram of microbial isolation from intestinal epithelial cells for in vitro and in vivo phenotypic assays. The invasive features, proliferation-inducing ability, and tumorigenic characteristics of the intraepithelial bacteria obtained from mouse colonocytes were evaluated in human cell lines and experimental murine models. (B) The intraepithelial E. coli strains (LI60C3, HM784C1, HM926C2, and HM936C4), adherent-invasive E. coli strains (LF82 and NC101), and nonpathogenic laboratory strains (MG1655, DH5α and JM109) were exposed to Caco-2 cells at MOI = 10 for 4 h. (a) Intracellular bacterial counts and (b) apical bacterial counts in the epithelial cultures are shown. (C) Cell cycle progression of Caco-2 cells after bacterial exposure for 24 h. The cell ratios in (a) S/G2/M to G1/G0 phase and (b) high to low Ki67 staining intensity are shown. Data are expressed as mean ± SEM ( N = 5–8/group). Each dot represents the data of one sample. * P < 0.05 vs. w/o, and # P < 0.05 vs. LI60C3. (D) A murine model with chemically induced colon cancer was inoculated with PBS vehicle, LI60C3, or LF82 at 10 9 CFU per mouse via the orogastric route. Representative images of intestinal tumors in each mouse group are displayed. Bar: 2 mm (macroscopic images) and 200 μm (histological images, H&E staining). (E) Increased tumor load was observed in mice inoculated with LI60C3, but not LF82. The tumor (a) number, (b) area, and (c) grade were determined for each mouse. The percentages of tumors with low- and high-grade dysplasia and carcinoma in each group are presented. Data are expressed as mean ± SEM ( N = 8–10/group). Each dot represents the data of one mouse. * P < 0.05 vs. PBS, and # P < 0.05 vs. LI60C3. The statistical significance of all panels is calculated by ANOVA followed by Tukey’s multiple comparison test, except those of (B-a), (C-a) and (E-a) are determined by the Kruskal–Wallis test. Experiments were repeated at least twice.

    Article Snippet: The cells were then fixed with ice-cold 70% ethanol overnight, followed by washing with PBS containing 1% bovine serum albumin (BSA) (Cat. #A2153, Sigma-Aldrich) and centrifuged at 1500 × g for 5 min. After decanting the supernatant, the cells were stained with a primary antibody rabbit anti-human Ki67 (Cat. #9129) (1:400, Cell Signaling, Beverly, MA, USA) in PBS containing 0.5% TWEEN-20 (Cat. #TWN508, BioShop, Burlington, ON, Canada) and 1% BSA for 1 h at room temperature.

    Techniques: Isolation, In Vitro, In Vivo, Bacteria, Staining, Comparison